National University Hospital of Iceland

Running trials

• Recruiting

  A multicenter, randomized, open-label, blinded-assessor, phase 4 study in patients with early rheumatoid arthritis to compare active conventional therapy versus three biologic treatments, and two de-escalation strategies in patients who respond to treatment.

  NCT01491815· Phase 4· Karolinska Institutet· Source

• Not yet recruiting

  bNAbs and Anti-PD-1 in HIV

  NCT07820813· Phase 2· Ole Schmeltz Søgaard· Source

• Active, not recruiting

  Safety, Tolerability and Biomarker-based Efficacy of NPI-001 (AT-001) in Subjects With MCI or Alzheimer's Disease (AD)

  NCT07741526· Phase 2· Arctic Therapeutics· Source

• Recruiting

  Primary treatment of follicular lymphoma with rituximab-lenalidomide-tafasitamab for high-risk disease and rituximab-lenalidomide with a 1:1 randomization to tafasitamab for low-risk disease: a phase II study – NLG-FL7

  2023-508196-36-00· Phase 2· Karolinska University Hospital· Source

• Recruiting

  Chemoablation or bladder resection with adjuvant chemotherapy in recurrent non-muscle invasive bladder cancer

  2022-502221-18-00· Phase 4· Aarhus University· Source

• Recruiting

  Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation

  NCT05679024· Phase 3· Region Stockholm· Source

• Recruiting

  SACK

  2022-501600-10-00· Phase 3· Karolinska University Hospital· Source

• Active, not recruiting

  Is there a survival benefit of administering thoracic radiotherapy concurrently with immunnotherapy and chemotherapy for patients with extensive stage small-cell lung cancer?

  NCT05223647· Phase 3· Norwegian University Of Science And Technolology· Source

• Enrolling by invitation

  Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM

  NCT04848506· Phase 2/3· Cytokinetics· Source

• Recruiting

  A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia

  NCT04307576· Phase 3· Mats Heyman· Source

• Active, not recruiting

  Ticagrelor and ASA vs. ASA Only After Isolated Coronary Artery Bypass Grafting in Patients With Acute Coronary Syndrome

  NCT03560310· Phase 4· Vastra Gotaland Region· Source

• Active, not recruiting

  Iceland Screens, Treats or Prevents Multiple Myeloma

  NCT03327597· Phase 2· University of Iceland· Source

• Recruiting

  Treatment as Prevention for Hepatitis C in Iceland

  NCT02647879· Landspitali University Hospital· Source

• Recruiting

  AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer.

  NCT02102165· Jules Bordet Institute· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Atrial fibrillation2 recruiting
• Chronic kidney disease2 recruiting
• Acute lymphoblastic leukaemia1 recruiting
• Bladder cancer1 recruiting
• Childhood cancers1 recruiting
• Follicular lymphoma1 recruiting
• Hepatitis C1 recruiting
• HIV1 recruiting
• Hypertrophic cardiomyopathy1 recruiting
• Multiple myeloma1 recruiting
• Rheumatoid arthritis1 recruiting
• Stroke1 recruiting

Closed trials

• Recruiting

  CHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients

  NCT06262438· Phase 2· Princess Maxima Center for Pediatric Oncology· Source

• Active, not recruiting

  A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)

  NCT06081894· Phase 3· Cytokinetics· Source

• Recruiting

  CHIP-AML22 Master protocol: Protocol for the treatment of children and adolescents with Acute Myeloid Leukemia (AML)

  2023-504999-25-00· Phase 3· Prinses Maxima Centrum voor Kinderoncologie B.V.· Source

• Completed

  Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Polymyalgia Rheumatica (PMR)

  NCT05767034· Phase 3· Novartis Pharmaceuticals· Source

• Terminated

  Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer

  NCT05132075· Phase 3· Novartis Pharmaceuticals· Source

• Completed

  Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis

  NCT05133336· Phase 2/3· Zydus Therapeutics Inc.· Source

• Completed

  The Nordic IBD Treatment Strategy Trial

  NCT05180175· Phase 4· Region Örebro County· Source

• Completed

  NORDTREAT Prospective Study on Inflammatory Bowel Disease

  NCT05414578· University of Southern Denmark· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Ankylosing spondylitis7 works · 0 trials